A pan-cancer analysis of the oncogenic function of HMGB1 in human tumors
This pan-cancer study of <i>HMGB1</i> underscores its potential as a signature marker and target for the management of various tumor types.
Authors
- Yu Pu (ORCID: https://orcid.org/0000-0002-7461-3788)
- Xiaokun Zhao (ORCID: https://orcid.org/0000-0002-3425-1882)
- Dandan Wei (ORCID: https://orcid.org/0000-0002-5597-6233)
- Zhe Li (ORCID: https://orcid.org/0000-0003-0493-8322)
- Xiaoling Li (ORCID: https://orcid.org/0000-0002-2313-2845)
- Xi Wang (ORCID: https://orcid.org/0000-0002-7572-6354)
- Hui-Min Yang (ORCID: https://orcid.org/0000-0002-0316-6116)
Institutions
- Shanghai Medical College of Fudan University (CN)
- Jiading District Central Hospital (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Shuguang Hospital (CN)
Publication Details
- Journal
- Biochemistry and Biophysics Reports
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1016/j.bbrep.2024.101851
- Citations
- 1
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.38